3 Biotech Stocks to Watch for Respectable Growth Beyond AI
Artificial intelligence has dominated investor attention for two years, but biotech revenue lines ar…
247wallst.com

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
+31.7% vs SMA 50 · +52.0% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $5.5M $3.3M–$7.7M | — | -$4.41 | — | ±1% | High8 |
FY2026(current) | $125000 $75249–$174800 | ▼ -97.7% | -$3.76 | — | ±13% | High9 |
FY2027 | $39.6M $34.6M–$44.7M | ▲ +31619.3% | -$3.18 | — | ±3% | High6 |
Artificial intelligence has dominated investor attention for two years, but biotech revenue lines ar…

No description available.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
AVBP◀ | $30.33 | -3.54% | $1.3B | — | — | — | 1500 |
| $68.56 | -3.59% | $13.3B | — | +12626.1% | -14525.8% | 1500 | |
| $513.72 | -0.71% | $11.8B | — | +43205.3% | -3008.0% | 1500 | |
| $87.60 | +0.60% | $11.5B | — | +3288.2% | -4239.0% | 1500 | |
| $183.72 | -1.59% | $10.7B | 29.2 | +1871.5% | 680.1% | 1500 | |
| $206.53 | -0.59% | $10.6B | — | +6554.5% | -2868.8% | 1500 | |
| $74.81 | +1.81% | $10.5B | 51.8 | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -1.09% | — | 40.5 | +398893.5% | -3996.9% | 1500 |